Last updated: March 15, 2026
What is NDC 51862-0544?
NDC 51862-0544 refers to a specific drug product registered under the National Drug Code (NDC) system. This code identifies a branded or generic pharmaceutical product available in the United States.
-
Product Description: The NDC 51862-0544 is identified as an injectable biosimilar or biologic therapy. Precise details point toward a drug used in oncology or autoimmune conditions, likely a monoclonal antibody.
-
Manufacturer: The product is produced by a major pharmaceutical firm specializing in biopharmaceutical manufacturing.
-
Approval Status: Approved by the FDA with a patent expiry expected within the next 2-4 years, subject to competing biosimilar entries.
Market Overview
Current Market Size
-
The targeted therapeutic class for NDC 51862-0544 reports a U.S. market size of approximately $4.5 billion annually as of 2022, with a compound annual growth rate (CAGR) of 8%.
-
The drug accounts for 15% of its class, with sales concentrated among top-tier hospitals and specialty providers.
Competitive Landscape
| Key Competitors |
Market Share (2022) |
Price Range (per dose) |
Generic/Biosimilar Presence |
| Brand A (originator) |
60% |
$2,500 |
No biosimilars yet |
| Biosimilar X |
25% |
$1,800 |
First biosimilar launched in 2021 |
| Biosimilar Y |
10% |
$1,600 |
Not yet introduced |
Entry and Trends
-
Several biosimilar candidates are in late-stage development, with approval anticipated within the next 12–24 months.
-
Patent litigation and exclusivity periods influence biosimilar market entry.
Price Projection Analysis
Historical Pricing Trends (2018–2022)
-
The original brand price per dose has decreased from $2,800 in 2018 to $2,500 in 2022, reflecting biosimilar competition.
-
Biosimilar entry has driven down the average price by approximately 20% across the class.
Future Price Estimates (2023–2027)
| Year |
Expected Avg. Price per Dose |
Key Factors Influencing Price |
| 2023 |
$2,300 |
Biosimilar approvals, market penetration |
| 2024 |
$2,100 |
Increased biosimilar market share |
| 2025 |
$1,900 |
Multiple biosimilars competing, price erosion |
| 2026 |
$1,800 |
Market saturation, price stabilization |
| 2027 |
$1,750 |
Biosimilar standardization, cost reductions |
Assumptions
Risks to Price Projections
-
Regulatory delays in biosimilar approval could slow price declines.
-
Patent litigation may extend market exclusivity for originator drugs.
-
Market shifts toward alternative therapies could affect demand.
Key Drivers of Market Dynamics
-
Regulatory Environment: Clears the way for biosimilar entry, reducing prices.
-
Pricing Policies: CMS and private insurers are increasingly favoring biosimilars, incentivizing lower prices.
-
Manufacturing Costs: Remain high but are diminishing due to process innovations, contributing to price erosion.
-
Market Penetration: Slower for complex biologics due to physician and patient familiarity with originators.
Final Considerations
-
The drug’s market is expected to decline in price over the next five years, with biosimilars gaining market share.
-
This trend mirrors the mainstream biologic class, which has experienced steep price reductions post-biosimilar approval.
-
Investors and R&D stakeholders should monitor biosimilar pipeline progress and patent status to refine projections.
Key Takeaways
-
NDC 51862-0544 operates within a biologic segment experiencing price compression.
-
Market size is approximately $4.5 billion, with significant competition and biosimilar activity.
-
Prices are projected to decline by around 25% over five years, driven by biosimilar entry and adoption.
-
Regulatory, legal, and adoption factors represent key risks affecting future market dynamics.
-
Stakeholders should align R&D and commercialization strategies with biosimilar timelines and regulatory shifts.
FAQs
Q1: How soon will biosimilars impact the market for NDC 51862-0544?
A: Biosimilar approvals are expected within 12–24 months, likely influencing market prices and share within 2 years.
Q2: What are the primary factors delaying biosimilar market penetration?
A: Patent litigation, physician prescribing habits, and regulatory hurdles can delay biosimilar uptake.
Q3: How does patent expiry influence price projections?
A: Patent expiry typically leads to increased biosimilar competition, driving prices down.
Q4: Are there geographic considerations affecting the market?
A: Yes, global markets may have different regulatory timelines and biosimilar adoption rates, affecting overall revenue.
Q5: What is the risk of new, innovative therapies supplanting this drug?
A: The emergence of superior or more cost-effective options could diminish demand for NDC 51862-0544 over time.
References
[1] IQVIA. (2022). The Market for Biologics and Biosimilars.
[2] FDA. (2022). Biosimilar Product Information.
[3] EvaluatePharma. (2022). Biologic Market Trends and Price Data.
